Biopharm boosts sales for Nabi
Nabi Biopharmaceuticals saw biopharmaceutical product sales - driven by strong growth in sales of Nabi-HB - reaching record levels of $89.5 million (€83m) in 2002, a 22 per cent increase from 2001 levels.
Archives for February 20, 2003
Cognis denies patent infringement
Cognis Nutrition & Health, a nutritional ingredients supplier, has responded to claims made earlier this week by Dutch rival Loders Croklaan regarding the infringement of several of its patents.
Mylan agreement over buspirone
US company Mylan Laboratories has reached a final agreement with Bristol-Myers Squibb, which resolves all disputes between the companies related to buspirone.
Canadian approval for Astra's Crestor
AstraZeneca Canada has received approval from the Therapeutic Products Directorate of Health Canada to market CRESTOR (rosuvastatin) 10 to 40 mg, a new medicine for the management of primary high cholesterol (primary hypercholesterolemia), familial...
Collaboration in anti-fungal drug discovery
Japanese company Kaken Pharmaceutical and US Elitra Pharmaceuticals said yesterday that they are to collaborate on a multi-year research project for the discovery and development of novel anti-fungal drugs.